{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-175113","form_type":"8-K","ticker":"BOLT","cik":"0001641281","company_name":"Bolt Biotherapeutics, Inc.","filed_at":"2024-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.918207+00:00","generated_at":"2026-05-31T23:29:41.060513+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bolt Biotherapeutics receives Nasdaq bid price deficiency notice; 180 days to comply","bullets":["Avg closing price of common stock fell below $1.00 over prior 30 trading days as of July 1, 2024.","180-day grace period until Dec 30, 2024 to regain compliance by closing at $1.00+ for 10 consecutive business days.","If not compliant, may qualify for an additional 180-day extension if other listing standards met.","Company intends to monitor bid price and evaluate options including potential reverse stock split.","Notice has no immediate effect on listing; stock continues trading on Nasdaq Global Select Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-175113","json":"https://secwatch.observer/filing/0001193125-24-175113.json","markdown":"https://secwatch.observer/filing/0001193125-24-175113.md","text":"https://secwatch.observer/filing/0001193125-24-175113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641281/000119312524175113/0001193125-24-175113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641281/000119312524175113/d796654d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:29:41.060513+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}